Caricamento...
Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer’s disease
OBJECTIVE: This study was mainly conducted to explore the expression changes of GSDMD and conventional markers (including T‐Tau, Tau181p, and Aβ(1–42)) in the cerebrospinal fluid among patients with Alzheimer's disease (AD) and vascular dementia (VD), followed by determination of role of GSDMD...
Salvato in:
| Pubblicato in: | Brain Behav |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8035446/ https://ncbi.nlm.nih.gov/pubmed/33587329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.2063 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|